Compare Ford Motor Company (F) vs Cassava Sciences Inc (FLNA) Price & Performance

Ford Motor Company (F) trades at $12.17, up 0.37% with a bearish technical outlook despite recent earnings beats. The company shows mixed fundamentals with $187.27B revenue but negative net income margin of -3.93% and concerning debt-to-asset ratio of 56.49%. Recent news highlights sales declines and production challenges, though the company maintains strong cash flow from operations of $21.28B. Analyst consensus remains cautiously optimistic with a $15.90 price target despite near-term headwinds.

Ford faces significant execution risks amid declining sales and competitive pressures, but valuation metrics appear attractive with P/E of 11.21 and P/S of 0.26. The hybrid vehicle transition and strong commercial division provide potential upside, though investors must weigh debt levels and margin pressures against the discounted valuation and analyst price target suggesting 30% upside potential.

FLNA trades at $0.8168 with minimal daily movement (+0.13%). The stock shows bearish technical signals with negative moving averages but has beaten earnings expectations for three consecutive quarters. Recent FDA approval to lift the clinical hold on simufilam enables Phase 2a epilepsy trials, providing potential catalyst. However, the company reports zero revenue, negative EBITDA of -$95.19M, and concerning cash flow trends with net cash outflow of -$33.07M in 2025.

While analyst consensus is strongly bullish (67% buy ratings), fundamental weaknesses including negative profitability metrics and cash burn present significant risks. The FDA approval provides near-term optimism for the epilepsy drug pipeline, but execution risk remains high given the company's financial position and lack of current revenue streams.